Showing results (61-70 of 229) with videos related to
Sort By:
Pageof 23
Journal of Vascular Surgery|July 14, 2026
"Hands Off": Best Practice Radiation Safety is Rarely Achieved in Microcatheter AngiographyEric Sleasman, Kiernan Gunn, Eric Davis, et al.Journal of Natural Products|December 20, 2008
Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosaTamara L Meragelman, Dominic A Scudiero, R Eric Davis, et al.Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.Anesthesiology|December 29, 2023
Anatomical Substrates of Rapid Eye Movement Sleep Rebound in a Rodent Model of Post-sevoflurane Sleep DisruptionNavya Atluri, Elzbieta Dulko, Michal Jedrusiak, et al.The Laryngoscope|October 8, 2014
Longitudinal variations of laryngeal overpressure and voice-related quality of life in spasmodic dysphoniaJeffrey C Yeung, Kevin Fung, Eric Davis, et al.British Journal of Haematology|May 23, 2018
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)Preetesh Jain, Jorge Romaguera, Samer A Srour, et al.Immunological Reviews|April 21, 2006
A library of gene expression signatures to illuminate normal and pathological lymphoid biologyArthur L Shaffer, George Wright, Liming Yang, et al.Experimental Hematology & Oncology|November 2, 2024
Vertical targeting of the PI3K/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphomaKristyna Kupcova, Jana Senavova, Filip Jura, et al.Leukemia & Lymphoma|April 11, 2015
Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapyMani Akhtari, Jay Paul Reddy, Chelsea C Pinnix, et al.Nature Reviews. Clinical Oncology|December 30, 2016
The landscape of new drugs in lymphomaAnas Younes, Stephen Ansell, Nathan Fowler, et al.Pageof 23